See All Slides - tctmd.com

Slides

Presentation TCT 2018

Full Body Embolic Protection During TAVR (Filterlex)

Presenter: Giora Weisz

September 21, 2018

Presentation TCT 2018

TCT-36: The Impact of Guideline-Directed Medical Therapy after Revascularization in Patients With Left Main Coronary Artery Disease: Analysis From the EXCEL Trial

Presenter: Nicholas J. Lembo, Marie-Claude Morice, R. Jay Widmer

September 21, 2018

Presentation TCT 2018

TCT-20: Left Ventricular Fluid Dynamics Simulation for Transcatheter Mitral Valve Replacement

Presenter: Eric Eeckhout, Glenn Van Langenhove, James Otton

September 21, 2018

Presentation TCT 2018

TCT-28: Repeat Chronic Total Occlusion Angioplasty Following an Unsuccessful CTO PCI Attempt: Predictors of Success and Association of Success with Angina Symptoms

Presenter: Jeffrey W. Moses, George W. Vetrovec, Adam C. Salisbury

September 21, 2018

Presentation TCT 2018

TCT-16: Incidence, Outcomes, And Microbiologic Profile Of Prosthetic Valve Endocarditis After TAVR And SAVR: Insights From PARTNER

Presenter: Charles J. Davidson, Jeffrey J. Popma, Matthew Summers

September 21, 2018

Presentation TCT 2018

TCT-24: Impact of Bleeding on Outcome and Predictive Value of Bleeding Scores in Patients With Cardiogenic Shock - a Substudy of the CULPRIT-SHOCK trial

Presenter: Angeles Alonso Garcia, Rajesh M. Dave, Anne Freund

September 21, 2018

Presentation TCT 2018

TCT-12: Elevated FFR Values at the Acute Moment in Non-Culprit Vessels of STEMI Patients due to Decreased Adenosine Responsiveness: A Comparison with the Adenosine Free iFR

Presenter: Allen Jeremias, Nina Van der Hoeven

September 21, 2018

Presentation TCT 2018

Catheter-Based Therapy for Acute Pulmonary Embolism: What Does the Data Tell Us?

Presenter: Raghu Kolluri, Mahmood K. Razavi, Akhilesh K. Sista

September 21, 2018

Presentation TCT 2018

The Methods for Coronary Stent Development

Presenter: Mitchell W. Krucoff, Gregg W. Stone, Chuck Simonton

September 21, 2018

Presentation TCT 2018

Bioprosthetic or Native Aortic Scallop Intentional Laceration to Prevent Iatrogenic Coronary Artery Obstruction During Transcatheter Aortic Valve Replacement: A Prospective IDE Trial (BASILICA)

Presenter: Jaffar M Khan

September 21, 2018

Advertisement

Slides

Full Body Embolic Protection During TAVR (Filterlex)

TCT-36: The Impact of Guideline-Directed Medical Therapy after Revascularization in Patients With Left Main Coronary Artery Disease: Analysis From the EXCEL Trial

TCT-20: Left Ventricular Fluid Dynamics Simulation for Transcatheter Mitral Valve Replacement

TCT-28: Repeat Chronic Total Occlusion Angioplasty Following an Unsuccessful CTO PCI Attempt: Predictors of Success and Association of Success with Angina Symptoms

TCT-16: Incidence, Outcomes, And Microbiologic Profile Of Prosthetic Valve Endocarditis After TAVR And SAVR: Insights From PARTNER

TCT-24: Impact of Bleeding on Outcome and Predictive Value of Bleeding Scores in Patients With Cardiogenic Shock - a Substudy of the CULPRIT-SHOCK trial

TCT-12: Elevated FFR Values at the Acute Moment in Non-Culprit Vessels of STEMI Patients due to Decreased Adenosine Responsiveness: A Comparison with the Adenosine Free iFR

Catheter-Based Therapy for Acute Pulmonary Embolism: What Does the Data Tell Us?

The Methods for Coronary Stent Development

Bioprosthetic or Native Aortic Scallop Intentional Laceration to Prevent Iatrogenic Coronary Artery Obstruction During Transcatheter Aortic Valve Replacement: A Prospective IDE Trial (BASILICA)

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content